title: Deeper Insights Into Vanishing Bile Duct Syndrome in Lymphoma: A Perplexing Entity.
authors.affiliation: Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Vishwanath
authors.initials: V
authors.lastname: Sathyanarayanan
authors.affiliation: Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Wai Chin
authors.initials: WC
authors.lastname: Foo
authors.affiliation: Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Michelle
authors.initials: M
authors.lastname: Fanale
authors.affiliation: Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: jwestin@mdanderson.org.
authors.forename: Jason
authors.initials: J
authors.lastname: Westin
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001652:Bile Ducts / Q000473:pathology*; D001663:Bilirubin / Q000378:metabolism; D001706:Biopsy; D002779:Cholestasis / Q000175:diagnosis* / Q000209:etiology*; D006801:Humans; D008099:Liver / Q000473:pathology; D008223:Lymphoma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D049268:Positron-Emission Tomography; D013577:Syndrome; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D001663:Bilirubin
keywords: Chemotherapy; Hepatic dysfunction; Hodgkin lymphoma; Liver failure; Review